Delivery Order SPE2DB20D2104-SPE2DB25FMSFR
- Not listed
- The Defense Logistics Agency awarded a $11,940.80 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,801.80 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml doses). This firm fixed-price delivery order, with an ultimate completion date of June 3, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $6,354.48 under a firm fixed-price contract. This non-set-aside delivery order, which is due for completion by July 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,584.97 for Trulicity 3 mg/0.5 ml pens on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price contract, which was not set-aside, represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,772.87 with a completion date of July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,293.62 and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract includes no set-aside designation and is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $8,408.40 with a completion date of September 30, 2025. This non-competitive delivery order represents a firm fixed price transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply agreement running through...
- The Defense Logistics Agency awarded a $3,298.53 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $13,633.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on April 24, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSFRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a ceiling value of $8,768.74. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with a completion date of June 3, 2025. As a leading pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen serves the Defense Logistics Agency's Medical Supply Chain by providing a comprehensive range of pharmaceutical products, including specialty medications and brand-name drugs across multiple therapeutic domains. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime indefinite delivery vehicle enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Trulicity, a diabetes medication, represents one of the specialized pharmaceutical products within the company's extensive portfolio of federal medical deliveries, demonstrating AmerisourceBergen's role as a key supplier for Department of Defense and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 6/2/25 |